> Outline
> Program
> Abstracts
> Venue
> Registration
> Contact
> Back to main site
Preliminary Program
> Printversion (pdf) 
Day 1 _ Thursday, June 28, 2012
11.45-12.15 Registration
12.15-12.30 Welcome
  Herbert Gottweis, Life-Science-Governance Research Platform, University of Vienna
12.30-13.30 First Key Note
  Chair: Georg Lauss, Life-Science-Governance Research Platform, University of Vienna
  Nikolas Rose, Department of Social Science, Health & Medicine, King’s College, London
  Who wants biomarkers? Who needs biomarkers?: The science and politics of personalized medicine
13.30-15.00 First Panel: Past biomarkers and “everyday biomarkers”
  Chair: Anna Durnová, Life-Science-Governance Research Platform, University of Vienna
  Michael Penkler, Department of Social Studies of Science, University of Vienna
  Everyday biomarkers, body weight and transformations of the self
  Martyn Pickersgill, Centre for Population Health Sciences, University of Edinburgh
  The mark of the psychopath: Biology, psychology, and the ambiguity of ontology
  Kristin Harðardóttir, University of Iceland and Ingrid Metzler, Life-Science-Governance Research Platform, University of Vienna
  Cultures of evidence: What we might learn from the PSA controversy
15.00-15.30 Coffee Break
15.30-16.30 Second Panel: Taming Alzheimer ’s disease
  Chair: Martyn Pickersgill, Centre for Population Health Sciences, University of Edinburgh
  Marianne Boenink and Anna Laura van der Laan,
Department of Philosophy, University of Twente, The Netherlands
  Proteins, diseases and guidelines: Biomarkers for Alzheimer’s disease and their role in the translational process
BLANK
  Yvonne Cuijpers, Harro van Lente, Ellen Moors, University of Utrecht
  Assessing the implications of early diagnostics for Alzheimer’s disease
BLANK
16.30-17.30 Second Key Note
  Chair: Ursula Naue,Life-Science-Governance Research Platform, University of Vienna
BLANK
  Margaret Lock, Department of Social Studies of Medicine, McGill University, Montreal
  Tracking amyloid biomarkers: The cornerstone for Alzheimer prevention
BLANK
   
Day 2 _ Friday, June 29, 2012
BLANK
9.00-10.00 Third Key Note
  Chair: Ingrid Metzler, Life-Science-Governance Research Platform, University of Vienna
BLANK
  Pascale Bourret, Aix-Marseille Université & UMR SESSTIM and
Alberto
Cambrosio, McGill
  A roadmap to personalized oncology? The trials and tribulations of breast cancer biomarkers
BLANK
10.00-11.00 Third Panel: Local configurations and other visions
  Chair: Paul Just, Life-Science-Governance Research Platform, University of Vienna
BLANK
  Nadine Levin, Institute of Social and Cultural Anthropology, University of Oxford
  Discovering local configurations of personalized medicine: from single gene markers to metabolic biomarker panels
BLANK
  Haidan Chen, Asia Research Institute, National University of Singapore
  EGFR Biomarker: Taming uncertainties and unknowns
BLANK
11.00-11.30 Coffee Break
BLANK
11.30-12.30 Fourth Panel: Pharmacogenomics: Past visions and expected futures
  Chair: Ingrid Schneider, University of Hamburg
BLANK
  Stuart Hogarth, King's College London, and Paul Martin, University of Sheffield
  “Pharmacogenetics is dead and warfarin killed it.” Techno-enthusiasm and clinical scepticism in the translation of drug response biomarkers
BLANK
  Dr Richard Tutton, ESRC Cesagen, Department of Sociology, Lancaster University
  Promising Biomarkers: Exuberance and exasperation in pharmacogenomics
BLANK
12.30-13.30 Lunch Break
BLANK
13.30-14.30 Fourth Key Note
  Chair: Anna Durnova,Life-Science-Governance Research Platform, University of Vienna
BLANK
  Barbara Prainsack, CBAS, Brunel University
  Making the mark: What the quantification of life in medicine can learn from forensics
BLANK
14.30-15.15 Fifth Key Note
  Chair: Walburg Steurer, Life-Science-Governance Research Platform, University of Vienna
BLANK
  Ingrid Schneider, University of Hamburg
  Biomarkers and intellectual property protection
BLANK
15.15-15.45 Coffee Break
BLANK
15.45-16.45 Fifth Panel: Bio-markers and Bio-economies
  Chair: Christian Haddad, Life-Science-Governance Research Platform, University of Vienna
BLANK
  Maggie Curnutte, Program on Science, Technology and Society, Harvard University
  After medicine: The direct-to-consumer genetic testing industry
BLANK
  Francis Lee, Unit of Technology and Social Change, Linköping University
  Making biomarkers for personalized medicine: Processes of valuation in mapping and research design
BLANK
16.30-17.00 Wrap up session
 
BLANK
 

 

    This conference is organized by the Life Science Governance Research Platform